Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLX | Deferred Stock Units | Award | $0 | +138 | +0.91% | $0.00 | 15.4K | Nov 9, 2023 | Common Stock | 138 | Direct | F1, F2, F3 | |
transaction | CLX | Deferred Stock Units | Award | $0 | +1.12K | +7.26% | $0.00 | 16.5K | Dec 29, 2023 | Common Stock | 1.12K | Direct | F1, F3, F4 | |
transaction | CLX | Deferred Stock Units | Award | $0 | +228 | +1.38% | $0.00 | 16.7K | Dec 29, 2023 | Common Stock | 228 | Direct | F1, F3, F5 |
Id | Content |
---|---|
F1 | 1-for-1 |
F2 | Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. |
F3 | The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
F4 | Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. |
F5 | Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. |